Progress in Vaccinology

Progress in Vaccinology by G. P. Talwar.

Vaccines have historically been considered to be the most cost-effective method for preventing communicable diseases. It was a vaccine that en­ abled global eradication of the dreaded disease smallpo. .

Saved in:
Bibliographic Details
Main Author: Talwar, G. P. (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 1989.
Edition:1st ed. 1989.
Series:Progress in Vaccinology, 2
Springer eBook Collection.
Subjects:
Life sciences.
Hepatology.
Gastroenterology .
Allergy.
Medical microbiology.
Immunology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • I Opening Remarks
  • 1. Vaccinology: The Two Revolutions
  • II Public Health Perspective—The Present Scene
  • 2. Vaccinology and the Goal of Health for All
  • 3. Toward Universal Immunization: 1990
  • 4. New and Improved Techniques for Vaccine Production
  • 5. Transfer of Vaccine Production to the Developing World: Rabies Vaccine
  • 6. Policy for Developing Countries for Storage, Distribution, and Use of Essential Vaccines for Immunoprophylaxis
  • III Environmental Factors Modulating The Efficacy of The Vaccine
  • 7. Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria
  • 8. Geographic Variation in Vaccine Efficacy: The Polio Experience
  • IV Hepatitis
  • 9. Molecular Immunology of Viral Antigens in Hepatitis B Vaccinations
  • 10. Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection
  • 11. Enterically Transmitted Hepatitis Viruses: Prospects for Control
  • 12. Immunological Characterization of a Viral Agent Involved in Epidemic and Sporadic Non-A Non-B Hepatitis
  • V Gastrointestinal Infections
  • 13. Attenuated Oral Typhoid Vaccine Ty 21a
  • 14. Oral B Subunit—Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial
  • 15. Prospects of Immunization Against Cholera by Adhesive Antigen
  • 16. Protective Antigens of Vibrio cholerae
  • 17. Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children
  • 18. Mucosal Immunity in the Gastrointestinal Tract in Relation to ETEC Vaccine Development
  • 19. Shigella Vaccines
  • 20. DNA Sequence Homology Among Genes of Shigella spp. and Enteroinvasive Escherichia coli..
  • 21. Mucosal and Acquired Immunity in Giardiasis and Its Relation to Diarrhea and Malabsorption
  • 22. Immunology of Entamoeba histolytica in Human and Experimental Hosts
  • 23. Molecular Comparisons Among Entamoeba histolytica Strains Using DNA and Protein Profiles
  • VI Filariasis
  • 24. Importance of Antibody Class in Helminth Infections
  • 25. Immunodiagnosis of Filariasis
  • VII Veterinary Vaccines
  • 26. Development, Production, and Application of Vaccines in Foot-and-Mouth Disease Control in India
  • 27. Cell Culture Vaccine Against Bovine Tropical Theileriosis
  • VIII Leprosy
  • 28. Present Approaches to Immunotherapy and Immunoprophylaxis for Leprosy
  • 29. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy
  • 30. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens Cross-Reactive with Three Major Protein Antigens of Mycobacterium leprae
  • 31. Molecular Approaches to Developing a Vaccine for Leprosy,
  • 32. Immunodiagnosis of Leprosy
  • 33. Immunodiagnostic Approaches to the Detection of M. leprae Infection in Leprosy
  • 34. Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA
  • IX Malaria and Leishmaniasis
  • 35. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein
  • 36. Malaria Sporozoite Vaccine Development: Recent Progress
  • 37. Community-Based Integrated Vector Control of Malaria in India
  • 38. Leishmaniasis and Malaria: New Tools for Epidemiological Analysis
  • X New Approaches to Vaccinology
  • 39. Vaccinia Virus Expression Vectors
  • 40. Vaccinia Recombinants Expressing Foreign Antigens: Antiviral and Antitumor Immunity
  • 41. Liposomes as Carriers of Vaccines
  • 42. A Short Primer on Vaccine Design: Focus on the Interrelatedness of Antigenic Determinants Addressing Various Lymphocyte Sub-populations
  • 43. Next Steps in the Evolution of Vaccinology.

Similar Items